Rani Therapeutics (NASDAQ:RANI – Free Report) had its price objective trimmed by Bank of America from $19.00 to $17.00 in a research note released on Monday, MarketBeat.com reports. The firm currently has a buy rating on the stock. Several other research analysts also recently issued reports on RANI. Cantor Fitzgerald reiterated an overweight rating on […]
Rani Therapeutics Holdings, Inc (NASDAQ:RANI) Given Average Rating of Buy by Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) – Equities research analysts at HC Wainwright cut their Q3 2023 earnings estimates for shares of Rani Therapeutics in a research report issued to clients and investors on Monday, August 14th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per share of […]
Rani Therapeutics (NASDAQ:RANI – Get Free Report)‘s stock had its “outperform” rating reaffirmed by investment analysts at Wedbush in a note issued to investors on Wednesday, RTT News reports. They presently have a $20.00 price target on the stock. Wedbush’s target price indicates a potential upside of 380.77% from the stock’s previous close. A number […]